Pfizer Valuation

PFE Stock  USD 27.75  0.03  0.11%   
At this time, the company appears to be undervalued. Pfizer Inc holds a recent Real Value of $33.17 per share. The prevailing price of the company is $27.75. Our model determines the value of Pfizer Inc from analyzing the company fundamentals such as Operating Margin of (0.50) %, return on equity of 0.0235, and Shares Outstanding of 5.66 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors support purchasing undervalued entities and exiting overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Price Book
1.7672
Enterprise Value
215.5 B
Enterprise Value Ebitda
22.5448
Price Sales
2.6964
Forward PE
12.837
Undervalued
Today
27.75
Please note that Pfizer's price fluctuation is very steady at this time. Calculation of the real value of Pfizer Inc is based on 3 months time horizon. Increasing Pfizer's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Pfizer Inc is useful when determining the fair value of the Pfizer stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Pfizer. Since Pfizer is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pfizer Stock. However, Pfizer's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  27.75 Real  33.17 Target  38.67 Hype  27.75 Naive  27.55
The real value of Pfizer Stock, also known as its intrinsic value, is the underlying worth of Pfizer Inc Company, which is reflected in its stock price. It is based on Pfizer's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Pfizer's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pfizer's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
33.17
Real Value
34.58
Upside
Estimating the potential upside or downside of Pfizer Inc helps investors to forecast how Pfizer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pfizer more accurately as focusing exclusively on Pfizer's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.340.540.76
Details
Hype
Prediction
LowEstimatedHigh
26.3427.7529.16
Details
Potential
Annual Dividend
LowForecastedHigh
1.031.091.15
Details
25 Analysts
Consensus
LowTarget PriceHigh
35.1938.6742.92
Details

Pfizer Investments

(30.66 Billion)

Pfizer Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Pfizer's current stock value. Our valuation model uses many indicators to compare Pfizer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pfizer competition to find correlations between indicators driving Pfizer's intrinsic value. More Info.
Pfizer Inc is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in five year return category among related companies reporting about  0.38  of Five Year Return per Price To Earning. The ratio of Price To Earning to Five Year Return for Pfizer Inc is roughly  2.63 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pfizer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pfizer's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pfizer's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pfizer's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pfizer and how it compares across the competition.

About Pfizer Valuation

The stock valuation mechanism determines the current worth of Pfizer Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Pfizer Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Pfizer Inc based exclusively on its fundamental and basic technical indicators. By analyzing Pfizer's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Pfizer's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pfizer. We calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies.
Last ReportedProjected for 2024
Gross Profit29.3 B30.4 B
Pretax Profit Margin 0.02  0.02 
Operating Profit Margin 0.07  0.07 
Net Profit Margin 0.04  0.03 
Gross Profit Margin 0.50  0.62 

8 Steps to conduct Pfizer's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pfizer's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pfizer's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Pfizer's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Pfizer's revenue streams: Identify Pfizer's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Pfizer's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Pfizer's growth potential: Evaluate Pfizer's management, business model, and growth potential.
  • Determine Pfizer's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pfizer's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Pfizer's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Pfizer's value is low or high relative to the company's performance and growth projections. Determining the market value of Pfizer can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Pfizer represents a small ownership stake in the entity. As a stockholder of Pfizer, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Pfizer Dividends Analysis For Valuation

At present, Pfizer's Dividend Payout Ratio is projected to increase slightly based on the last few years of reporting. . At present, Pfizer's Price Earnings Ratio is projected to increase significantly based on the last few years of reporting.
Last ReportedProjected for 2024
Dividends Paid-9.2 B-8.8 B
Dividend Yield 0.06  0.06 
Dividend Payout Ratio 4.36  4.58 
Dividend Paid And Capex Coverage Ratio 1.63  1.55 
There are various types of dividends Pfizer can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Pfizer shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Pfizer Inc directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Pfizer pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Pfizer by the value of the dividends paid out.

Pfizer Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Pfizer does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding5.7 B
Quarterly Earnings Growth Y O Y-0.764
Forward Price Earnings12.837

Pfizer Current Valuation Indicators

Valuation refers to the process of determining the present value of Pfizer Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Pfizer we look at many different elements of the entity such as Pfizer's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Pfizer's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Pfizer's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Pfizer, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Pfizer's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Pfizer's worth.
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.